INM
Price
$3.87
Change
+$1.42 (+57.96%)
Updated
Jun 24 closing price
Capitalization
4.67M
PYPD
Price
$3.58
Change
-$0.10 (-2.72%)
Updated
Jun 24 closing price
Capitalization
36.48M
42 days until earnings call
Interact to see
Advertisement

INM vs PYPD

Header iconINM vs PYPD Comparison
Open Charts INM vs PYPDBanner chart's image
InMed Pharmaceuticals
Price$3.87
Change+$1.42 (+57.96%)
Volume$109.98M
Capitalization4.67M
PolyPid
Price$3.58
Change-$0.10 (-2.72%)
Volume$340.27K
Capitalization36.48M
INM vs PYPD Comparison Chart in %
Loading...
INM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PYPD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INM vs. PYPD commentary
Jun 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INM is a Hold and PYPD is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 25, 2025
Stock price -- (INM: $2.45 vs. PYPD: $3.68)
Brand notoriety: INM and PYPD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INM: 5% vs. PYPD: 87%
Market capitalization -- INM: $4.67M vs. PYPD: $36.48M
INM [@Biotechnology] is valued at $4.67M. PYPD’s [@Biotechnology] market capitalization is $36.48M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.36B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INM’s FA Score shows that 0 FA rating(s) are green whilePYPD’s FA Score has 0 green FA rating(s).

  • INM’s FA Score: 0 green, 5 red.
  • PYPD’s FA Score: 0 green, 5 red.
According to our system of comparison, PYPD is a better buy in the long-term than INM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INM’s TA Score shows that 3 TA indicator(s) are bullish while PYPD’s TA Score has 5 bullish TA indicator(s).

  • INM’s TA Score: 3 bullish, 5 bearish.
  • PYPD’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, PYPD is a better buy in the short-term than INM.

Price Growth

INM (@Biotechnology) experienced а +3.38% price change this week, while PYPD (@Biotechnology) price change was +0.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.91%. For the same industry, the average monthly price growth was +35.46%, and the average quarterly price growth was +17.29%.

Reported Earning Dates

INM is expected to report earnings on May 12, 2025.

PYPD is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+4.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PYPD($36.5M) has a higher market cap than INM($4.67M). PYPD YTD gains are higher at: 21.053 vs. INM (-46.623). INM has higher annual earnings (EBITDA): -7.86M vs. PYPD (-29.31M). PYPD has more cash in the bank: 8.04M vs. INM (4.68M). INM has less debt than PYPD: INM (849K) vs PYPD (8.83M). INM has higher revenues than PYPD: INM (4.92M) vs PYPD (0).
INMPYPDINM / PYPD
Capitalization4.67M36.5M13%
EBITDA-7.86M-29.31M27%
Gain YTD-46.62321.053-221%
P/E Ratio0.01N/A-
Revenue4.92M0-
Total Cash4.68M8.04M58%
Total Debt849K8.83M10%
FUNDAMENTALS RATINGS
INM: Fundamental Ratings
INM
OUTLOOK RATING
1..100
96
VALUATION
overvalued / fair valued / undervalued
1..100
39
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
87
P/E GROWTH RATING
1..100
82
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INMPYPD
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
89%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
83%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
72%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
72%
Advances
ODDS (%)
Bullish Trend 24 days ago
83%
Bullish Trend 16 days ago
74%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
INM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PYPD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RSVR7.590.10
+1.34%
Reservoir Media
MMLP3.130.03
+0.97%
Martin Midstream Partners LP
QLGN3.61-0.01
-0.25%
Qualigen Therapeutics Inc
CNK31.06-0.83
-2.60%
Cinemark Holdings
PR14.10-0.63
-4.28%
Permian Resources Corp

INM and

Correlation & Price change

A.I.dvisor indicates that over the last year, INM has been loosely correlated with TTNP. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if INM jumps, then TTNP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INM
1D Price
Change %
INM100%
-1.61%
TTNP - INM
44%
Loosely correlated
+4.48%
EYEN - INM
39%
Loosely correlated
+30.17%
OMER - INM
36%
Loosely correlated
-0.93%
VTYX - INM
31%
Poorly correlated
+6.19%
PULM - INM
30%
Poorly correlated
-7.00%
More

PYPD and

Correlation & Price change

A.I.dvisor indicates that over the last year, PYPD has been loosely correlated with VTYX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if PYPD jumps, then VTYX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PYPD
1D Price
Change %
PYPD100%
+12.20%
VTYX - PYPD
37%
Loosely correlated
+6.19%
AMLX - PYPD
29%
Poorly correlated
-0.59%
MESO - PYPD
29%
Poorly correlated
-2.64%
INM - PYPD
28%
Poorly correlated
-1.61%
VRAX - PYPD
28%
Poorly correlated
-4.27%
More